In humans, a single base mutation in BAG3 leads to an amino acid exchange (P209L) causing severe childhood restrictive cardiomyopathy, muscular dystrophy, respiratory insufficiency, and peripheral polyneuropathy1 resulting in increased mortality by the second decade (OMIM MFM6 #612954). Here, BAG3 is linked to restrictive cardiomyopathy.